Form 4 Filing for SOPHiA GENETICS SA

On April 20, 2026, Zhenyu Xu, Chief Scientific Officer of SOPHiA GENETICS SA, sold 608 ordinary shares in an open market transaction. This sale was executed as part of a pre-established Rule 10b5-1(c) trading plan to cover tax withholding obligations associated with restricted stock unit vesting on April 18, 2026. The shares were sold at a weighted average price of $5.2053 per share, with individual transactions ranging from $5.10 to $5.29. Following this transaction, Mr. Xu directly owns 630,888 ordinary shares. The filing was made on Form 4, indicating a change in beneficial ownership.